UBS AM’s Eikon Therapeutics EIKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04K Buy
+130
New +$1.31K ﹤0.01% 4119

Other funds holding EIKN

UBS AM's EIKN Position: Q3 2026 in Review

UBS AM opened a new position in Eikon Therapeutics (EIKN) in Q3 2026: 130 shares worth $1.04K. The stake represents ﹤0.01% of the portfolio and ranks #4119 among its holdings.

75 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • UBS AM held 130 shares of Eikon Therapeutics worth $1.04K as of Q3 2026.
  • Eikon Therapeutics was a new UBS AM position in Q3 2026.
  • Eikon Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4119 holding.
  • 75 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.